Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business (NASDAQ: MYL), nature s pharma.#Nature #s #pharma

Posted On Mar 4 2018 by

Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business PITTSBURGH, July 14, 2010 /PRNewswire via COMTEX News Network/ — Mylan Inc. (Nasdaq: MYL) today announced plans to acquire Bioniche Pharma Holdings Limited, a privately held, global injectable pharmaceutical company for $550 million in cash. Bioniche Pharma will provide Mylan not only an immediate entry into the North American injectables market but also a platform for future growth opportunities. This transaction is expected to be accretive to Mylan’s earnings in year one, without accounting for any operational or other synergies. Mylan Chairman and CEO Robert J. Coury said: “We are extremely …

The Fortune 500 s fastest-growing pharmaceutical companies #pharmaceutical #machinery

Posted On Jan 8 2018 by

#pharmaceutical industry growth # These are the Fortune 500’s fastest-growing pharma companies The pharmaceutical industry has been rocked in recent years by a confluence of patent expirations of blockbuster drugs, increasing competition from generics and new governmental and industry efforts to control costs the world over. That s made growth prospects for many pharma companies a risky and uncertain proposition. Some have pursued growth via innovative (and expensive) new drugs, like Gilead Science s hepatitis C treatment, Sovaldi, which can cost $84,000 for a full course. Some (see: Actavis) have pursued an aggressive acquisition strategy, buying their way to growth …

The year s top pharma marketing controversies – Medical Marketing and Media #pharmaceutical #companies #in #nyc

Posted On Jan 8 2018 by

#marketing pharmaceuticals # December 23, 2015 The year’s top pharma marketing controversies Photo credit: Bill Brooks/Creative Commons 1. Drug pricing goes public: In the past year, what was once an issue debated among few stakeholders in the medical community became a talking point in presidential campaigns. (Bill Clinton’s words of advice to pharma: “Explain, explain, explain; disclose, disclose, disclose.”) The issue of how and why drugs are priced the way they are hit a tipping point, as insurers, pharmacy benefit managers, physicians and even presumptive presidential candidates questioned pharmaceutical pricing practices and called for changes to the current system. 2. …

Seamus Mulligan s Azur to merge with US pharma firm in $500m deal – Rockwell College Union #par #pharma

Posted On Dec 31 2017 by

#azur pharma # Seamus Mulligan’s Azur to merge with US pharma firm in $500m deal Sunday, 16th October 2011 IRISH PHARMA group Azur, which is led by former Elan executive Séamus Mulligan (1977), has agreed to merge with Nasdaq-listed Jazz Pharmaceuticals in a deal that values the Dublin-based company at $500 million (365.5 million). Seamus was the 2005 Union Business Lunch guest speaker. This is an all-share transaction that will give Azurs shareholders just over 20 per cent of the combined entity. Jazzs owners will hold the balance. The deal, which was announced in California on Monday, is subject to …

Painkiller marketing secrets? Check Chicago – s unredacted suit against Endo, Purdue, Cephalon, et al #q #pharma

Posted On Dec 27 2017 by

#chicago pharmaceutical companies # Painkiller marketing secrets? Check Chicago s unredacted suit against Endo, Purdue, Cephalon, et al. The city of Chicago made big news when it sued 5 drugmakers, alleging that their painkiller marketing broke the law. But much of the juicy detail in that lawsuit was hidden from view, redacted under a confidentiality agreement with the companies. Now, it’s open for viewing. As Bloomberg reports, a federal judge ruled that the information filed under seal could be made public, despite objections from two of the companies. The city then filed an amended complaint that’s mostly redaction-free. So, what …

India s Sun Pharma Gets U #pharmaceutical #research #companies

Posted On Dec 27 2017 by

#sun pharma # India’s Sun Pharma Gets U.S. Subpoena Over Generic Drugs Pricing The U.S. Department of Justice (DoJ) has subpoenaed India s largest drugmaker Sun Pharmaceutical Industries Ltd seeking information about the pricing and marketing of the generic drugs it sells in the United States, the company said on Saturday. The DoJ s antitrust division has also asked Sun Pharma s U.S. unit for documents related to employee and corporate records and communications with competitors. The subpoena comes amid a wider probe by U.S. regulators into steep increases in the prices of generic medicines in recent years. For more …

China – s Drug-Price Cuts Are Hitting Big Pharma Where It Hurts #anabolic #pharma

Posted On Dec 27 2017 by

#chinese pharmaceutical companies # China’s Drug-Price Cuts Are Hitting Big Pharma Where It Hurts The world’s largest pharmaceutical companies are facing a roadblock in China as a state-led campaign to slash drug prices has triggered a slowdown in sales growth. One of the biggest problems: China’s government-run health insurance funds, which are struggling to keep up with an ageing population and surging incidence of diseases like cancer or diabetes. As they grapple with tighter budgets and a slowing economy, many of these funds are capping reimbursements to patients and pushing local authorities to negotiate with companies to lower drug prices. …

Raptor Pharma to Stop Development of Liver Drug: Here – s Why: Healthy Living

Posted On Dec 26 2017 by

#raptor pharma # Raptor Pharma to Stop Development of Liver Drug: Here s Why Raptor Pharma announced that it will no longer pursue the development of its experimental drug RP103 as treatment for the liver disease Nonalcoholic steatohepatitis in children. (Photo. Bill Brooks | Flickr) Raptor Pharmaceutical Corporation is pulling the plug on an experimental drug as treatment for a liver disease. In a statement released on Monday, Sept.14, the biopharmaceutical company said that the drug called RP103 (cysteamine bitartrate) did not meet the main goals in the Phase 2b CyNCh study. The study, which involved 169 participants between 8 …

Big Pharma Jobs – India s No1 Pharma Recruitment Consulting company #7tm #pharma

Posted On Dec 26 2017 by

#big pharma jobs # India Presence Ahmedabad, Delhi, Vizag, Gandhinagar,Vadodara, Aurangabad, Rewari – Haryana, Bangalore, Pune, Lucknow & Ghaziabad Global Presence UK, UAE, Bangadesh, USA & Canada 60+ Pharma Domain Experts And Many More. EXPERTISE ACROSS PHARMA SEGMENTS EXPERTISE ACROSS PHARMA FUNCTIONS PHARMA CORPORATE FUNCTIONS PHARMA PLANT FUNCTIONS PHARMA R /* 728×90, создано 05.02.11 */ google_ad_slot = “6127977750”; google_ad_width = 670; google_ad_height = 90; //–>

India – s first CRM for Pharma used by 10k Medical Reps in 5 countries #q #pharma

Posted On Dec 26 2017 by

#crm for pharma # Mobile Daily Call Reporting(DCR) Medismo On Demand Healthcare Mobile CRM lets you report from anywhere. MRs can Track Doctor Previous Call History, Stop False Reporting via GPS Tracking. Use the power of Medismo Pharma Mobile CRM to track your Medical rep locations and travel expenses sitting in Head Office. Pharma CRM in SaaS The BI Reporting engine can give reports in Realtime to track sales sales funnel so that the Managers can take proactive action. CEOs and Managers have access to a Single screen snapshot of sales, performance, competitor activity, expenses to the company much more. …